United StatesNiacin Extended-release Tablets, USP 1,000 mg in 90‑count prescription bottles (NDC 62175‑322‑46), lot 25282724A, exp. 2027/01, distributed by Lannett Company, Inc., Philadelphia, PA, are being recalled nationwide in the United States (3,984 bottles). The recall was initiated because 12‑month long‑term stability testing was out of specification for low Stage 3 dissolution at the 24‑hour timepoint.
What's being recalled
Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.
Recalling firm: Lannett Company Inc., Seymour, IN, United States.
How to identify it
Lot #: 25282724A, Exp. Date 2027/01
The hazard
Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide within the United States
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)